Cargando…
LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men
The gastric hormone ghrelin stimulates food intake and increases plasma glucose through activation of the growth hormone secretagogue receptor (GHSR). Liver-expressed antimicrobial peptide 2 (LEAP2) has been proposed to inhibit actions of ghrelin through inverse effects on GHSR activity. Here, we in...
Autores principales: | Hagemann, Christoffer A., Jensen, Malene S., Holm, Stephanie, Gasbjerg, Lærke S., Byberg, Sarah, Skov-Jeppesen, Kirsa, Hartmann, Bolette, Holst, Jens J., Dela, Flemming, Vilsbøll, Tina, Christensen, Mikkel B., Holst, Birgitte, Knop, Filip K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043997/ https://www.ncbi.nlm.nih.gov/pubmed/35492241 http://dx.doi.org/10.1016/j.xcrm.2022.100582 |
Ejemplares similares
-
Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake
por: Hagemann, Christoffer A., et al.
Publicado: (2023) -
Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2
por: Holm, Stephanie, et al.
Publicado: (2022) -
Gluco-metabolic effects of oral and intravenous alcohol administration in men
por: Lanng, Amalie R, et al.
Publicado: (2019) -
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
por: Schiellerup, Sine Paasch, et al.
Publicado: (2019) -
Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
por: Baldassano, Sara, et al.
Publicado: (2019)